Free Trial

Evelo Biosciences (EVLO) News Today

Evelo Biosciences logo
$0.0015 0.00 (0.00%)
(As of 11/22/2024 ET)
Evelo Biosciences, Inc. (EVLO)
FMR LLC Reduces Stake in Evelo Biosciences Inc
Evelo Biosciences Inc EVLO
Q3 2023 Horizon Technology Finance Corp Earnings Call
Evelo (EVLO) Drops 59% on Flunking Psoriasis Drug Study
Evelo drops as mid-stage trial for psoriasis drug fails
Evelo Biosciences shares tank 46% after trial failure
EVLO - Evelo Biosciences, Inc.
Why Is Evelo Biosciences (EVLO) Stock Up 51% Today?
Get Evelo Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for EVLO and its competitors with MarketBeat's FREE daily newsletter.

Missed Nvidia? Watch this ASAP (Ad)

This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrough so advanced, it’s going to make ChatGPT look like VHS. But what’s even more unbelievable? I believe it’ll make Nvidia’s meteoric rise look like a backyard bottle rocket.

Click here and I’ll tell you everything you need to know.

EVLO Media Mentions By Week

EVLO Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

EVLO
News Sentiment

0.00

0.49

Average
Medical
News Sentiment

EVLO News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

EVLO Articles
This Week

1

0

EVLO Articles
Average Week

Get Evelo Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for EVLO and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:EVLO) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners